Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors Nanjing Sike Pharmaceutical
- 26 Aug 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 07 Jul 2014 Planned primary completion date changed from 1 Oct 2014 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 02 Dec 2013 New trial record